Paris, France

Gilles Dutruc-Rosset


 

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 107(Granted Patents)


Company Filing History:


Years Active: 1983-2009

Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: Gilles Dutruc-Rosset: Pioneering Innovator in Pharmaceutical Patents

Introduction: Gilles Dutruc-Rosset is a prominent inventor based in Paris, France, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 19 patents, he has focused his research on developing novel compounds that have the potential to address critical health issues.

Latest Patents: Among his most recent innovations is the patent for the "Use of aminoindazole derivatives for the inhibition of tau phosphorylation." This invention concerns the application of novel derivatives of general formula (I) to tackle tau phosphorylation, which is a key factor in various neurodegenerative disorders. Another noteworthy patent involves the "Inhibition of casein kinase Iε," where Dutruc-Rosset discloses and claims compounds of formula (I) with specific molecular configurations. These compounds have been shown to be effective in treating central nervous system diseases, including mood and sleep disorders. The patents also include pharmaceutical compositions and methods for the preparation of these innovative compounds.

Career Highlights: Gilles Dutruc-Rosset has built a reputable career in the pharmaceutical industry, having worked with renowned companies such as Aventis Pharma S.A. and Rhône-Poulenc Rorer S.A. His expertise in drug development and patenting has positioned him as a leading figure in his field.

Collaborations: Throughout his career, Gilles has collaborated with talented individuals like Dominique Lesuisse and Thomas Rooney. These collaborations have contributed to the advancement of his research and the success of his inventions.

Conclusion: Gilles Dutruc-Rosset's work exemplifies the power of innovation in medicine. With his extensive experience and numerous patents, he continues to make strides in addressing complex medical challenges through his groundbreaking research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…